Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use

Personalized dendritic cell- (DC-) based vaccination has proven to be safe and effective as second-line therapy against various cancer types. In terms of overall survival, there is still room for improvement of DC-based therapies, including the development of more immunostimulatory DC vaccines. In t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Immunol Res
Autori principali: Van den Bergh, J. M. J., Smits, E. L. J. M., Versteven, M., De Reu, H., Berneman, Z. N., Van Tendeloo, V. F. I., Lion, E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5530419/
https://ncbi.nlm.nih.gov/pubmed/28785596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/1975902
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi